Sanctura Articles
Indevus makes $105M placing
1 September 2008
Allergan gets Canadian right to Sanctura
2 June 2008
Indevus' loss doubles on charges in fiscal 2007
10 December 2007
Allergan buys Esprit Pharma for $370M in cash
27 September 2007
Indevus gets $49.9M milestone from Esprit
20 August 2007
Indevus' Sanctura XR approved by US FDA
13 August 2007
Indevus licenses European Sanctura XR rights to Madaus
13 November 2006
Strong Ph III data for Indevus' Sanctura XR
17 July 2006
Indevus closes Sanctura transaction with Esprit
11 July 2005
Pliva's overactive bladder drug Sanctura launched in USA
13 September 2004
Indevus' Sanctura cleared by FDA
7 June 2004
Indevus and Pliva to co-promote Sanctura
12 April 2004
Indevus files for OAB drug trospium in USA
5 May 2003
Interneuron revenues up on Sarafem royalty
25 February 2002
Interneuron begins Ph III trospium trial
7 September 2001
Interneuron crashes again as citicoline fails in stroke
13 January 2000
Showing 1-16 of 16 articles
- 1
- Is failure to adopt business process management putting the pharma industry at risk?
- New Zealand declines Alexion's funding application for Solaris
- HIV vaccines: small biotech and government-funded organizations will step in where Big Pharma has fallen short, says analyst
- Ignyta acquires Actagene Oncology and entry into cancer personalized medicine
- Elan makes "transformational" acquisitions and a divestment
